Conditionally MYC: insights from novel transgenic models.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Letters

• Publication date

  2005-08-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANLET.2004.10.043PMID 16039948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism

  2004cited by this paper
• Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer.

  2004cited by this paper
• Adenovirus Vector-Mediated Doxycycline-Inducible RNA Interference

  2004cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia

  2004influential reference
• Developmental Context Determines Latency of MYC-Induced Tumorigenesis

  2004cited by this paper
• Reversible lymphomagenesis in conditionally c‐MYC expressing mice

  2004influential reference
• Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue.

  2004cited by this paper
• Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations.

  2003cited by this paper
• Myc pathways provoking cell suicide and cancer

  2003cited by this paper
• Cancer revoked: oncogenes as therapeutic targets

  2003cited by this paper
• Pharmacological inactivation of MYC for the treatment of cancer.

  2003cited by this paper
• c-MYC: more than just a matter of life and death

  2002cited by this paper
• Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression

  2002cited by this paper
• Cancer modeling in the modern era: progress and challenges.

  2002cited by this paper
• The myc oncogene: MarvelouslY Complex.

  2002cited by this paper
• Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

  2002cited by this paper
• Conditional mouse models of sporadic cancer

  2002cited by this paper
• Deconstructing myc.

  2001cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism

  1999cited by this paper
• Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.

  1999cited by this paper
• Reversible tumorigenesis by MYC in hematopoietic lineages.

  1999cited by this paper
• Transient excess of MYC activity can elicit genomic instability and tumorigenesis.

  1999cited by this paper
• C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression

  1998cited by this paper
• Oncogene alterations in primary, recurrent, and metastatic human bone tumors

  1996cited by this paper
• Analysis of oncogenes, tumor suppressor genes, autocrine growth‐factor production, and differentiation state of human osteosarcoma cell lines

  1995cited by this paper
• Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer.

  1994cited by this paper
• Inducible gene expression systems for higher eukaryotic cells.

  1994cited by this paper
• The myc gene family proteins and their role in transformation and differentiation.

  1990cited by this paper
• 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target

  1988cited by this paper
• Oncogene amplification in tumor cells.

  1986cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

  1984cited by this paper
• c‐myc involvement in chromosomal translocations in mice and men

  1984cited by this paper
• Significance of chromosome change to hematopoietic neoplasms.

  1983cited by this paper
• Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin μ locus in a Burkitt lymphoma

  1983cited by this paper
• Retroviruses and cancer genes.

  1982cited by this paper

• The MiR-561 Suppresses Glioblastoma Cell Proliferation through C-myc Regulation

  2021cites this paper
• An "-omycs" Toolbox to Work with MYC.

  2021cites this paper
• MYC inhibitors in multiple myeloma

  2021cites this paper
• FGFR1 is associated with c‐MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti‐angiogenic therapy

  2020cites this paper
• Molecular cloning and functional characterization of MYC transcription factor in pathogen-challenged Apostichopus japonicus.

  2019cites this paper
• MYC-induced metabolic stress and tumorigenesis.

  2018cites this paper
• Investigating the therapeutic potential of NUAK1 for the treatment of colorectal cancer

  2018cites this paper
• Identification of Novel Protein Interacts with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma

  2017cites this paper
• Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.

  2017cites this paper
• STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence

  2017cites this paper
• The potential of multi-compound nanoparticles to bypass drug resistance in cancer

  2017cites this paper
• Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer

  2016cites this paper
• مقایسه تکثیر و بیان انکوژن C-MYC در سرطان معده در جمعیت ایرانی با دو روش CISH و IHC

  2015cites this paper
• Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.

  2015cites this paper
• Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.

  2015cites this paper
• MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism

  2015cites this paper
• C-MYC AMPLIFICATION AND EXPRESSION IN STOMACH CANCER SAMPLES IN IRANIAN POPULATION USING TWO TECHNIQUES OF CISH AND IHC

  2015cites this paper
• Inactivation of MYC reverses tumorigenesis

  2014cites this paper
• Bringing order to disorder : structural and functional analysis for development of strategies to target myc

  2014cites this paper
• MYC activation is a hallmark of cancer initiation and maintenance.

  2014cites this paper
• The Myc world within reach.

  2013cites this paper
• Study human pancreatic cancer in mice: how close are they?

  2013cites this paper
• Role of MYCN in retinoblastoma.

  2013cites this paper
• Selective androgen receptor modulators in cancer cachexia?

  2013cites this paper
• Bioluminescence Imaging of Mouse Pancreas

  2013cites this paper
• Prevalência e Associação da Infecção por Helicobacter pylori e do Vírus de Epstein-Barr em Adenocarcinoma Gástrico, em uma População do Norte do Brasil.

  2012cites this paper
• A mouse model to study inducible oncogene cooperation in vivo

  2012cites this paper
• “Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

  2012cites this paper
• Finding cancer's weakest link

  2011cites this paper
• 7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.

  2011cites this paper
• Bioluminescent imaging: a critical tool in pre‐clinical oncology research

  2010cites this paper
• Selective activation of apoptosis by a novel set of 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones through a Myc-dependent pathway.

  2009cites this paper
• ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.

  2009cites this paper
• Myc's other life: stem cells and beyond.

  2009cites this paper
• Control transcripcional de la diferenciación celular

  2009cites this paper
• The c-myc promoter: still MysterY and challenge.

  2008cites this paper
• Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest

  2008cites this paper
• c-Myc Inhibits Ras-Mediated Differentiation of Pheochromocytoma Cells by Blocking c-Jun Up-Regulation

  2008cites this paper
• Modelling Myc inhibition as a cancer therapy

  2008cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007influential citation
• Establishment and controlled differentiation of neural crest stem cell lines using conditional transgenesis.

  2007cites this paper
• A Conserved Pathway That Controls c-Myc Protein Stability through Opposing Phosphorylation Events Occurs in Yeast*

  2007cites this paper
• NOTCH and PI3K-AKT pathways intertwined.

  2007cites this paper
• Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis

  2007cites this paper
• Interactions Between Myc- and Cyclin-DependentKinase Inhibitors in Cancer

  2007cites this paper
• The Myc oncoprotein as a therapeutic target for human cancer.

  2006cites this paper
• C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil.

  2006cites this paper
• Imaging and oncologic drug development.

  2006cites this paper
• Two decades of cancer genetics: from specificity to pleiotropic networks.

  2005cites this paper